About
At GenEdit, we aim to overcome the existing limitations in genetic medicine so we can positively impact the lives of as many people as possible.
Our co-founders Kunwoo Lee, Ph.D., Hyo Min Park, Ph.D., and Niren Murthy, Ph.D., worked closely with Nobel Laureate Jennifer Doudna, Ph.D., (Chemistry, 2020) at UC Berkeley and recognized that identifying the right delivery strategy was the critical step in realizing the potential of CRISPR/Cas9 and other genetic medicines.
GenEdit’s mission is to discover and develop innovative genetic medicines with targeted in vivo delivery. With our team’s collective expertise, we are currently advancing novel therapies and realizing a new era of genetic medicine: one in which we can edit out disease and rewrite patient health.